TEVA PHARMACEUTICAL INDUSTRIES LIMITED Proceeds from Common Stock Issued
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) reported Proceeds from Common Stock Issued of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-12.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2019-02-19
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED proceeds from issuance of common stock for the quarter ending 2017-12-31 was $0.00.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED proceeds from issuance of common stock for the quarter ending 2017-09-30 was $0.00.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED proceeds from issuance of common stock for the quarter ending 2017-06-30 was $0.00.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED proceeds from issuance of common stock for the quarter ending 2017-03-31 was $0.00, a 100.00% decline year-over-year.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED proceeds from issuance of common stock for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED proceeds from issuance of common stock for fiscal 2016 was $329.00M, a 90.00% decline from fiscal 2015.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED proceeds from issuance of common stock for fiscal 2015 was $3.29B.
| Period end | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 6-K 9 month · filed 2018-02-12 | $0.00 derived: sum of 2 quarters · filed 2018-02-12 | $0.00 derived: sum of 3 quarters · filed 2018-02-12 | $0.00 10-K · filed 2018-02-12 |
| 2017-09-30 | $0.00 derived: 6-K 9 month − 6-K 6 month · filed 2017-11-02 | $0.00 derived: sum of 2 quarters · filed 2017-11-02 | $0.00 6-K · filed 2017-11-02 | $0.00 derived: sum of 4 quarters · filed 2018-02-12 |
| 2017-06-30 | $0.00 derived: 6-K 6 month − 6-K 3 month · filed 2017-08-03 | $0.00 6-K · filed 2017-08-03 | $0.00 derived: sum of 3 quarters · filed 2018-02-12 | $0.00 derived: sum of 4 quarters · filed 2018-02-12 |
| 2017-03-31 | $0.00 6-K · filed 2017-05-11 | $0.00 derived: sum of 2 quarters · filed 2018-02-12 | $0.00 derived: sum of 3 quarters · filed 2018-02-12 | $0.00 derived: sum of 4 quarters · filed 2018-02-12 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 6-K 9 month · filed 2018-02-12 | $0.00 derived: sum of 2 quarters · filed 2018-02-12 | $0.00 derived: sum of 3 quarters · filed 2018-02-12 | $329.00M 10-K · filed 2019-02-19 |
| 2016-09-30 | $0.00 derived: 6-K 9 month − 6-K 6 month · filed 2017-11-02 | $0.00 derived: sum of 2 quarters · filed 2017-11-02 | $329.00M 6-K · filed 2017-11-02 | $3.62B derived: sum of 4 quarters · filed 2018-02-12 |
| 2016-06-30 | $0.00 derived: 6-K 6 month − 6-K 3 month · filed 2017-08-03 | $329.00M 6-K · filed 2017-08-03 | $3.62B derived: sum of 3 quarters · filed 2018-02-12 | $3.62B derived: sum of 4 quarters · filed 2018-02-12 |
| 2016-03-31 | $329.00M 6-K · filed 2017-05-11 | $3.62B derived: sum of 2 quarters · filed 2018-02-12 | $3.62B derived: sum of 3 quarters · filed 2018-02-12 | $3.62B derived: sum of 4 quarters · filed 2018-02-12 |
| 2015-12-31 | $3.29B derived: 10-K 12 month − 6-K 9 month · filed 2018-02-12 | $3.29B derived: sum of 2 quarters · filed 2018-02-12 | $3.29B derived: sum of 3 quarters · filed 2018-02-12 | $3.29B 10-K · filed 2018-02-12 |
| 2015-09-30 | $0.00 derived: 6-K 9 month − 6-K 6 month · filed 2016-11-15 | $0.00 derived: sum of 2 quarters · filed 2016-11-15 | $0.00 6-K · filed 2016-11-15 | |
| 2015-06-30 | $0.00 derived: 6-K 6 month − 6-K 3 month · filed 2016-08-04 | $0.00 6-K · filed 2016-08-04 | ||
| 2015-03-31 | $0.00 6-K · filed 2016-05-09 |